Shopping Cart

IBX Secures Additional Capital — Shareholders Exercise Options

IBX Secures Additional Capital — Shareholders Exercise Options

Imagion Biosystems Limited announce that it has received $1.29m for the exercise of unlisted options issued under the terms of the 2018 Rights Issue outlined in the information booklet dated 24 September 2018. The options were exercisable at 6 cents on or before 27 November 2020.

Read the announcement.

Related Articles

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.